SCH 527123

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

AsthmaChronic Obstructive Pulmonary Disease

Phase 1

Two-Part Study to Evaluate the Dose Response of SCH 527123 on Sputum Neutrophilia Following Ozone Challenge in Healthy Subjects and Chronic Obstructive Pulmonary Disease (COPD) Patients (P05567 AM7)

TerminatedNCT01068145

Merck Sharp & Dohme LLCChronic Obstructive Pulmonary Disease

Start: 2010-02-28End: 2011-03-31Updated: 2015-03-26

Phase 2

Study of SCH 527123 in Subjects With Severe Asthma (Study P05109AM1)

WithdrawnNCT01006161

Merck Sharp & Dohme LLCAsthma

Start: 2010-01-31End: 2012-08-31Updated: 2015-10-14